Long-Awaited Brexit White Paper Lays Out UK’s Plans For Medicines Regulation
Executive Summary
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
You may also be interested in...
UK OTC Group Chief Outlines Cautious Brexit Stance
Proprietary Association of Great Britain urges UK and EU to “ensure appropriate mutual recognition agreements are in place” following UK's Brexit withdrawal, says chief executive John Smith.
UK OTC Group Chief Outlines Cautious Brexit Stance
Proprietary Association of Great Britain urges UK and EU to “ensure appropriate mutual recognition agreements are in place” following UK's Brexit withdrawal, says chief executive John Smith.
Parliament Tells PM To Take 'All Necessary Steps' To Keep UK In EMA After Brexit
Members of parliament in the UK want the government to take "all necessary steps" to keep the country in the EU medicines regulatory network after Brexit. It's not that easy, though.